Ado-trastuzumab emtansine Intravenous and Arcapta Neohaler
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Arcapta Neohaler and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: indacaterol
Brand name: Arcapta Neohaler
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Ardeparin Subcutaneous
- Ado-trastuzumab emtansine Intravenous-Aredia
- Ado-trastuzumab emtansine Intravenous-Arestin
- Ado-trastuzumab emtansine Intravenous-Arestin eent
- Ado-trastuzumab emtansine Intravenous-Arestin mucous membrane powder
- Ado-trastuzumab emtansine Intravenous-Arformoterol
- Arcapta Neohaler-Adox Pak 2/100
- Arcapta Neohaler-Adoxa
- Arcapta Neohaler-Adoxa CK
- Arcapta Neohaler-Adoxa Pak
- Arcapta Neohaler-Adoxa Pak 1/100
- Arcapta Neohaler-Adoxa Pak 1/150